Unit of Endocrinology and Diabetes, Department of Medicine, University Campus Bio-Medico di Roma, Rome, Italy.
Diet and Diabetes Unit, ASL RM1, Rome, Italy.
Eat Weight Disord. 2022 Oct;27(7):2339-2346. doi: 10.1007/s40519-022-01434-2. Epub 2022 Jul 1.
Several studies have shown a strong correlation between the different types of diets and gut microbiota composition on glycemia and weight loss. In this direction, low-carbohydrate and ketogenic diets have gained popularity, despite studies published so far leading to controversial results on subjects with diabetes. In this narrative review, firstly, we aimed to analyze the role of very-low-calorie ketogenic diets (VLCKDs) in type 2 diabetes (T2DM) and obesity management. Secondly, in this context, we focused attention on gut microbiota as a function of VLCKD, particularly in T2DM and obesity treatment. Finally, we reported all this evidence to underline the importance of gut microbiota to exalt new nutritional strategies for "tailor-made" management, treatment, and rehabilitation in subjects with T2DM and obesity, even with diabetic complications. In conclusion, this narrative review outlined the beneficial impact of VLCKD on gut microbiota even in subjects with T2DM and obesity, and, despite inner VLCKD short-duration feature allowing no sound-enough provisions for long-term outcomes, witnessed in favor of the short-term safety of VLCKD in those patients.Level of evidence Level V: Opinions of authorities, based on descriptive studies, narrative reviews, clinical experience, or reports of expert committees.
多项研究表明,不同类型的饮食与肠道微生物群组成之间存在很强的相关性,这对血糖和体重减轻有影响。在这一方向上,低碳水化合物和生酮饮食已经流行起来,尽管到目前为止发表的研究对糖尿病患者的结果存在争议。在这篇叙述性综述中,我们首先旨在分析极低卡路里生酮饮食(VLCKD)在 2 型糖尿病(T2DM)和肥胖症管理中的作用。其次,在这种情况下,我们关注肠道微生物群作为 VLCKD 的一个功能,特别是在 T2DM 和肥胖症治疗中。最后,我们报告了所有这些证据,以强调肠道微生物群对“量身定制”管理、治疗和康复 T2DM 和肥胖症患者,甚至伴有糖尿病并发症患者的新营养策略的重要性。总之,本叙述性综述概述了 VLCKD 对肠道微生物群的有益影响,即使在 T2DM 和肥胖症患者中也是如此,尽管 VLCKD 的短期特征不能为长期结果提供足够的依据,但在这些患者中,VLCKD 的短期安全性得到了证实。证据水平 V:基于描述性研究、叙述性综述、临床经验或专家委员会报告的权威意见。